New Jersey Launches Investigation of Amgen’s Enbrel Marketing Practices
Lawsuits against Amgen by two former sales reps have led to a New Jersey state investigation of the company's marketing practices for the psoriasis drug Enbrel (etanercept)
Lawsuits against Amgen by two former sales reps have led to a New Jersey state investigation of the company's marketing practices for the psoriasis drug Enbrel (etanercept)